EPMA Journal

(The TQCC of EPMA Journal is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-09-01 to 2023-09-01.)
Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles112
Flavonoids against the Warburg phenotype—concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism75
Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised care71
Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients—indications for predictive, preventive, and personalized medical approach67
Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles59
All around suboptimal health — a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine57
An examination of colorectal cancer burden by socioeconomic status: evidence from GLOBOCAN 201854
Caution, “normal” BMI: health risks associated with potentially masked individual underweight—EPMA Position Paper 202150
Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope?49
COVID-19 what have we learned? The rise of social machines and connected devices in pandemic management following the concepts of predictive, preventive and personalized medicine47
Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions47
Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine46
Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine43
Can tailored nanoceria act as a prebiotic? Report on improved lipid profile and gut microbiota in obese mice39
Effect of probiotics on obesity-related markers per enterotype: a double-blind, placebo-controlled, randomized clinical trial37
Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person36
Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine35
Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine34
Probiotic Lactobacillus and Bifidobacterium strains possess safety characteristics, antiviral activities and host adherence factors revealed by genome mining34
Microbial and metabolomic analysis of gingival crevicular fluid in general chronic periodontitis patients: lessons for a predictive, preventive, and personalized medical approach34
Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes33
Identification of pathology-specific regulators of m6A RNA modification to optimize lung cancer management in the context of predictive, preventive, and personalized medicine31
Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways30
Covid-19 pandemic by the “real-time” monitoring: the Tunisian case and lessons for global epidemics in the context of 3PM strategies30